Medicare Enrolled
Dr. Michael Vacchio, M.D.
Urology Physician · Wyomissing, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vacchio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vacchio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vacchio
Dr. Michael Vacchio is an urology physician in Wyomissing, PA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Vacchio performed 4,433 Medicare services across 2,435 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vacchio received a total of $5,697 from 27 pharmaceutical and/or device companies across 107 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vacchio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 12% volume in PA
$5,697 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,433
Medicare services
Top 12% in PA for urology physician
2,435
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~341 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
1,248 | $34 | $53 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
515 | $3 | $12 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
467 | $7 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
462 | $83 | $255 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
457 | $59 | $163 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
288 | $69 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
165 | $104 | $376 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
96 | $34 | $53 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
96 | $34 | $53 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
96 | $34 | $53 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
89 | $8 | $171 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
84 | $2 | $9 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
78 | $175 | $686 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
59 | $36 | $125 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
40 | $43 | $154 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
31 | $3 | $10 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
27 | $19 | $37 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $100 | $271 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
18 | $231 | $530 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
16 | $89 | $945 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
15 | $131 | $467 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
14 | $145 | $364 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
14 | $241 | $432 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $68 | $210 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $40 | $111 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
11 | $27 | $337 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
11.1% medium
88.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,697
Total received (2019-2024)
Avg $949/year across 6 years
Top 25% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
107
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,189 (91.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$508 (8.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$851
2023
$3,233
2022
$624
2021
$661
2020
$243
2019
$84
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$346
BLUEWIND MEDICAL
$188
COLOPLAST CORP
$67
Teleflex LLC
$63
Bayer Healthcare Pharmaceuticals Inc.
$47
Boston Scientific Corporation
$42
Laborie Medical Technologies Corp.
$40
C. R. Bard, Inc. & Subsidiaries
$30
ABBVIE INC.
$28
Top 3 companies account for 70.6% of 2024 payments
All-time payments by company (2019-2024) ›
Axonics, Inc.
$3,277
Teleflex LLC
$755
Astellas Pharma US Inc
$377
Janssen Biotech, Inc.
$245
BLUEWIND MEDICAL
$188
NeoTract Inc.
$97
AstraZeneca Pharmaceuticals LP
$84
Coloplast Corp
$84
COLOPLAST CORP
$67
Boston Scientific Corporation
$59
ABBVIE INC.
$49
Bayer Healthcare Pharmaceuticals Inc.
$47
Medtronic, Inc.
$43
Laborie Medical Technologies Corp.
$40
Bayer HealthCare Pharmaceuticals Inc.
$39
UroGen Pharma, Inc.
$34
Blue Earth Diagnostics Limited
$34
C. R. Bard, Inc. & Subsidiaries
$30
Sumitomo Pharma America, Inc.
$20
Merck Sharp & Dohme Corporation
$19
Clarus Therapeutics Inc.
$18
Olympus America Inc.
$17
UROVANT SCIENCES INC
$17
AbbVie Inc.
$16
Intuitive Surgical, Inc.
$15
Ferring Pharmaceuticals Inc.
$13
Amgen Inc.
$13
Top 3 companies account for 77.4% of all-time payments
Associated products mentioned in payments ›
Axonics · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · Bulkamid · Da Vinci Surgical System · ERLEADA · FIRMAGON · GEMTESA · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Luja Coude · Lumenis Pulse 120H · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · Porges Coloplast · REVI · REZUM · SPEEDICATH · SpeediCath · UROLIFT · UroLift · UroLift System · XGEVA · XTANDI · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
27
Per 100K population
6.3
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vacchio is a clinical cardiology specialist, with above-average Medicare volume (top 12% in PA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vacchio experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Vacchio performed 1,248 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vacchio receive payments from pharmaceutical companies?
Yes. Dr. Vacchio received a total of $5,697 from 27 companies across 107 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vacchio's costs compare to other urology physicians in Wyomissing?
Dr. Vacchio's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vacchio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Wyomissing
Browse urology physicians in Wyomissing ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology